Clinical Trial Detail

NCT ID NCT03542175
Title A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

triple-receptor negative breast cancer

Therapies

Rucaparib

Age Groups: senior adult

No variant requirements are available.